Company Search:
Advanced Search
Sponsored Links
Astellas Pharma Incorporated Company Snapshot
Astellas Pharma Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Astellas Pharma Incorporated with three other companies in this sector in Japan: Daiichi Sankyo Company Limited (2016 sales of 986.45 billion Japanese Yen [US$9.54 billion] of which 94% was prescription drugs), Eisai Company Limited (547.92 billion Japanese Yen [US$5.30 billion] of which 49% was Pharmaceutical Business -Japan), and Takeda Pharmaceutical Company Limited (1.81 trillion Japanese Yen [US$17.48 billion] ).

Sales Analysis. Astellas Pharma Incorporated reported sales of ¥1.37 trillion (US$13.27 billion) for the fiscal year ending March of 2016. This represents an increase of 10.1% versus 2015, when the company's sales were ¥1.25 trillion. Sales at Astellas Pharma Incorporated have increased during each of the previous five years (and since 2011, sales have increased a total of 44%). Sales of Xtandi saw an increase that was more than double the company's growth rate: sales were up 83.7% in 2016, from ¥137.19 billion to ¥252.08 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Astellas Pharma Incorporated
  Stock Performance Chart for Astellas Pharma Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 1,525.00
(Figures in Japanese Yen)
1 Week -0.3%   13 Weeks -4.4%  
4 Weeks -7.9%   52 Weeks -7.5%  
Astellas Pharma Incorporated Key Data:
  Ticker: 4503 Country: Japan
  Exchanges: PAR TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,372,706,000,000
(Year Ending Jan 2017).
Employees: 17,217
  Currency: Japanese Yen Market Cap: 3,240,037,821,625
  Fiscal Yr Ends: March Shares Outstanding: 2,124,614,965
  Share Type: Common Closely Held Shares: 28,897,743
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.